Studies are supporting neuroprotective benefi t of therapeutic hypothermia in term newborns
INTRODUCTION
Hypoxic-ischemic encephalopathy (HIE) is a major cause of morbidity and mortality in neonates despite important progress in obstetric and neonatal care during the last decades. According to Lawn et al. (1) , it is the fi fth most common cause of death in children under 5 years. Perinatal asphyxia aff ects 3-5 newborns per 1000 live births with subsequent moderate or severe hypoxic ischemic encephalopathy in 0.5 to 1 per 1000 live births in developed countries (2) . These numbers are twice or more in developing countries (3) . Studies show that 10% to 60% of aff ected infants die, and at least 25% of survivors have long-term neurodevelopmental sequels (4) .
Therapeutic approach for treating neonatal encephalopathy has to be based on the understanding of the mechanisms of neuronal damage following hypoxic-ischemic brain injury. That pathway is probably our clue for fi nding the best possibilities for preventing brain injury in asphyxiated neonates. Animal models show that many factors play a role, e.g., etiology, extent of hypoxia or ischemia, maturation stage of the brain, regional cerebral blood fl ow, and general health prior to the injury can all impact the pattern and extent of brain injury as well as outcome following the injury (5) . Results of previous studies on this subject indicate that some other factors can play additional role, especially in developing countries, such as maternal nutrition, infections, late admission to hospital, lengthy decision making for cesarean section, etc. Today, general understanding of the pathophysiological processes in HIE is that the initial hypoxic-ischemic insult brings immediate cell loss of varying degrees, but delayed impairment in energy metabolism leads to more signifi cant cell loss by apoptotic cell death.
One of the ideas to try ameliorating this secondary brain injury is by putting neonates at risk of developing moderate to severe HIE on therapeutic hypothermia. A review of animal studies showed that brain cooling to 32 °C to 34 °C, beginning before 5.5 hours following hypoxic-ischemic injury and continued for 12-72 hours, reduced secondary energy failure and cell death and was associated with neuropathological and functional improvements (6) . Several human trials in which cooling was initiated as early as feasible after brain injury (but before 6 hours) and in which neonates rectal/esophageal temperature was reduced to 32 °C to 34 °C showed promising results. The potential mechanisms of neuroprotection with hypothermia include inhibition of glutamate release, reduction of cerebral metabolism, which in turn preserves high energy phosphates, decrease in intracellular acidosis and lactic acid accumulation, preservation of endogenous antioxidants, reduction of nitric oxide production, prevention of protein kinase inhibition, improvement of protein synthesis, reduction of leukotriene production, prevention of blood-brain barrier disruption and brain edema, and inhibition of apoptosis (7, 8) . Randomized controlled trials such as the CoolCap study (9) , National Institute for Child Health and Human Development (NICHD) Neonatal Research Network (10), TOBY Trial (11) and ICE Trial (12) have led to a growing number of centers around the world deciding to make this procedure part of their routine work. Two major diff erent methods are present today: whole-body cooling (nowadays prevailing) and selective head cooling (less used). There is no mutual consensus if one of these is superior, and debate is still going on (13) .
In this study, we tried to assess the outcome of children treated with therapeutic hypothermia for moderate and severe perinatal asphyxia, as well as the infl uence of several factors presented at admission to the hospital and discharge from the hospital on neurodevelopmental outcome.
PATIENTS AND METHODS
We assessed neurodevelopmental outcome of 25 children at diff erent age, which were after birth treated with therapeutic hypothermia. Infants were eligible for consideration of such a treatment if they were born at or after 36 completed weeks of gestation.
Protocols for selecting patients for therapeutic hypothermia treatment were revised from TOBY study and so called Bristol Cooling Protocol (14) (15) (16) . Revisions were made in a way that criteria for inclusion in hypothermia treatment by performing amplitude-integrated electroencephalography (aEEG) read by trained personnel were not obligatory if other criteria were met, and aEEG was done only in several patients.
This meant that infants with more than 36 weeks of gestation, and with at least one of the following: Apgar score ≤5 at ten minutes after birth, continued need for resuscitation, including endotracheal or mask ventilation at 10 minutes after birth, acidosis defi ned as either umbilical cord pH or any arterial, venous or capillary pH within 60 min of birth less than 7.00, or base defi cit greater than or equal to 16 mmol/L in umbilical cord blood sample or any blood sample within 60 minutes of birth (arterial or venous blood), were eligible for further evaluation for cooling. Next criteria were moderate to severe encephalopathy, consisting of altered state of consciousness (lethargy, stupor or coma), and at least one or more of the following: persistent hypotonia after successful resuscitation, abnormal refl exes including oculomotor or pupillary abnormalities, absent or weak suck, and clinical seizures as recorded by trained personnel. Children who meet these criteria largely correspond to stage II and III of Sarnat grading scale of HIE.
Only three infants in this group were studied by aEEG prior to cooling process, for at least 30 minutes duration, and another seven were monitored during cooling process. aEEG was assessed as: with continuous, normal background voltage without electrical seizure activity, moderately abnormal voltage (upper margin of trace >10μV and lower margin of trace <5μV), discontinuous, suppressed activity (upper margin of trace <10μV and lower margin of trace <5μV, and for seizure activity. aEEG was done with Nicolet ICU Monitor (CareFusion Corporation, San Diego, California, USA); four electrodes were placed in the P3-P4 and C3-C4 areas, fi fth electrode (neutral electrode) was placed to the front of the midline as a ground for noise immunity placement of electrodes.
Cooling duration was 72 hours, with at least 6 hours of rewarming. Rectal temperatures were set to 33.5 °C. Cooling was performed by the Arctic Sun Temperature Management System (Medivance, Louisville, Colorado, USA) as a thermoregulatory device that monitors and controls patient temperature within a range of 32 °C to 38.5 °C. The system consists of the Model 2000 and disposable Arctic Gel hydrogel coated pads. Cooling and rewarming was done in a preprogrammed way.
Mortality was ascertained up to the latest follow up. Children were followed-up for their neurodevelopment through
We were able to get ASQ-3 questionnaires for 19 of our patients at the time of fi nishing our follow up and their neurodevelopmental outcome according to the results from ASQ-3 questionnaires is presented in Table 3 .
It is worth noting that seven of 19 patients (36.8%) had completely normal results for all fi ve categories, while three (15.8%) had abnormal results for all categories. We tried to assess whether some of the parameters that were recorded at birth as well as during the recruiting process for therapeutic hypothermia and during hospital stay had any correlation with neurodevelopmental outcome. There was no statistically signifi cant correlation between these parameters and neurodevelopmental outcome. Results are shown in Table 4 .
We also tried to see if some features from neurological examination of the child on discharge from the hospital after therapeutic hypothermia for perinatal asphyxia could be correlated with outcome, and whether scoring these examinations (0 point -Abnormal, 1 point -Normal) could be helpful in predicting neurodevelopmental outcome. We did not fi nd any statistically signifi cant correlation. Results are shown in Table 5 .
Ten children in our group were monitored by aEEG, three prior and during, and seven only during therapeutic hypothermia. A prominent fi nding in eight of these patients was discontinuous background activity as described before, and two had a burst suppression pattern during recording.
DISCUSSION
The lack of specifi c interventions to improve frequently poor prognosis of neonates with moderate to severe peri- Resuscitation required at 10 min of age, n (%) 22 (88) Clinical seizures prior to cooling, n (%) 12 (48) regular visits at child neurology outpatient clinic, through a structured examination by one trained assessor. At the moment of fi nishing study, cross-sectional evaluation of their development was done by the parent and assistant, completing questionnaires based on the Ages & Stages Questionnaires (ASQ-3), adopted in a way described by Kapci et al. (17) , and use it as part of the project of introducing early intervention programs in Bosnia and Herzegovina. We decided to base our neurodevelopmental assessment on this parent-completed developmental and social-emotional screener questionnaire because of its highly valid, reliable and accurate results that span across the spectrum of ages, since we did not have enough patients in the age group above 18 or 24 months. ASQ shows sensitivity of 92%, 95% specifi city, 92% positive predictive value and 95% negative predictive value when used to detect severe developmental delay; and 67% sensitivity, 93% specifi city, 92% positive predictive value and 68% negative predictive value when used to detect both severe and mild developmental delay in children with neonatal HIE (18) . It has very good correlation with more sophisticated, time consuming tests, like Bayley scale, which require investigators' thorough education (19) . Parents were instructed to fi ll in the questionnaire during follow up visit. In the period of assessment, children were aged 4-36 months.
The IBM SPSS 20 software package was used for statistical analyses; descriptive statistics was used for description of the variables, means, medians, ranges and distribution of data. Mann-Whitney U Test was used to show signifi cance of independent variables in relation to dependent (neurodevelopmental outcome). Linear regression was tested.
RESULTS
The study was conducted from October 2010 to October 2013 at Pediatric Hospital, Sarajevo University Clinical Center, Sarajevo, Bosnia and Herzegovina. Children were recruited for the study from two maternity hospitals in Sarajevo and 9 other diff erent maternity hospitals in Bosnia and Herzegovina.
Compliance with the protocol was not complete in two patients, where cooling started after the age of 6 hours, due to decision of doctors on ward at that time. Baseline characteristics of the infants are shown in Table 1 .
Patient outcome, survival and age at testing according to categories of communication, gross motor, fi ne motor, problem solving, and personal-social skills for each of our patients treated with therapeutic hypothermia for perinatal asphyxia are shown in Table 2 . Four (16%) patients died and two (8%) were lost during follow up, but with no indication that they died.
natal asphyxia had made neonatologists eager to try novel treatments. Hypoxic-ischemic encephalopathy presents a huge problem for later health care of those patients, carrying signifi cant morbidity and mortality rates and leading to a signifi cant burden on society. In the last decade, one of the most promising new treatments has been therapeutic hypothermia for perinatal asphyxia.
Since this method is in widespread use in the world for less than 5 years, randomized trials are still scarce, and data from them are sometimes contradictory. A recent meta-analysis (18), however, states that it strongly supports the use of therapeutic hypothermia in newborns with HIE to reduce the risk of death and neurologic impairment at 18 months. But some other studies still show that a lot of things regarding therapeutic hypothermia have to be answered, and possibly, adjusting of therapy should be done in the coming years (19) .
Nowadays, many medical centers are starting 'cooling programs' , not only in highly developed countries, but also in developing countries. Results from less developed countries do not always correlate with those in highly developed countries, due to several reasons, and for this problem we have to put accent on factors such as maternal nutrition, scope of prenatal and perinatal infections, less developed medical transport services, lack of adequate hospital facilities, late admission to hospital and lengthy decision making for cesarean section, etc. That is why we tried to compare the results from Bosnia and Herzegovina with the results from other highly developed countries.
Our sample for the past three years was quite small and neurodevelopmental follow up frequently not long enough to make far-reaching conclusions. Our mortality rate for the followed period, four out of 25 patients (16%), was comparable or lower than in most other studies (9) (10) (11) (12) . From the available data, it is hard to comment on this, since there was no major diff erence in asphyxia severity, and our percentage can be part of a small number of patients we had in our group. n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a Duration of follow up was one of the issues of this study because all our patients were not followed up for the same time. There are no studies showing how long follow up period is needed for more accurate prediction of neurodevelopmental follow up in these children, and common sense would be that it should be as long as possible, but Azzopardi et al. (2012) found in their study that there were no signifi cant diff erences in clinical characteristics, aEEG prior to cooling, and age in hours after birth when cooling was started between the infants with and without 2-year outcome data available (20) .
On the part of gross and fi ne motor development we had little less good results. About 31% of children were having clearly abnormal gross motor development (half of them with hemiparesis) and further 10% were in retesting zone. Some 26% of our group had abnormal fi ne motor develop- Developmental outcome was also similar, with good results on regular neurodevelopmental follow up examinations. That was confi rmed by the results obtained through ASQ-3.
The results were really encouraging in the domains of communication, problem solving and personal-social performances, with normal behavior in about 70% of patients. Testing the reliability of ASQ-3 in these conditions, regarding the issues of sensitivity, specifi city, positive predictive value, negative predictive value, interobserver reliability remains uncertain (17), but we had good correlation with structured ment, but with further 37% of children in retesting zone. All these results are quite comparable to the studies mentioned above.
TOBY report (11) fi nds 27% of patients with severe neurodevelopmental disability in cooled group, and survival without neurologic abnormality in 44%. They also fi nd a normal GM-FCS score in 71%, which is somehow higher than our results. All those follow ups were quite short and we need longer periods, as a meta-analysis from 2010 states: "Continued follow up of the children enrolled in the studies included in our meta-analysis is essential to determine whether these benefi ts are maintained in later childhood" (18) .
Prior to starting cooling, during cooling and after it we recorded numerous parameters. We tried to see if some of them had any kind of correlation with neurodevelopmental outcome, but statistical methods used were restricted by a small number of patients in our group. We were not able to show that any of the studied parameters had statistically signifi cant infl uence on neurodevelopmental outcome, even the neurological examination at discharge from the hospital. We think that for such studies, much larger groups of patients are needed, and we need to have more multicenter studies dealing with this matter. Not too many studies have addressed this problem until now. Wyatt et al. (21) on a much larger sample of 218 children found a correlation of developmental outcome with treatment, lower encephalopathy grade, lower birth weight, greater aEEG amplitude, absence of seizures, and higher Apgar score, with better outcomes for children with these parameters. Bennet et al. (22) make a good point in emphasizing the need for better understanding of the potential role of biomarkers for HIE.
The need to perform aEEG before starting cooling, in the process of recruitment of candidates for therapeutic hypothermia for perinatal asphyxia remains one of greater controversies in this method. At the beginning of follow up period, our hospital did not have aEEG equipment, and we only had it for the last year of our work. In a recent prospective study (23) , the authors found that the aEEG background pattern at <9 hours did not signifi cantly enhance the predictive value of HIE stage at <6 hours in predicting death and disability at 18 months. Other researchers investigated the abilities of aEEG recordings during cooling and found that the recovery of the background pattern within 24 hours was associated with a lower rate of disability (defi ned as death, cerebral palsy, or developmental quotient <85) at 2 years (24) , and that the time to normalize aEEG was a better predictor than the time to establish normal sleep-wake cycling (25) . On the other hand, some large randomized trials included aEEG recordings in the recruitment process for therapeutic hypothermia to prevent HIE (11, 15, 16) .
From the perspective of our limited experience and fi rst steps in applying therapeutic hypothermia for perinatal asphyxia, we think that the results we are getting are highly promising. Our relatively small number of patients and limitations of study design (not a randomized, controlled study) make our conclusions less reliable, but we think that this can be a solid base for starting assessing the eff ects of therapeutic hypothermia in countries with limited health care resources. This study shows that improved managing of patients at risk of severe HIE can aff ect morbidity and mortality rates in less developed countries where this problem is much more present. 
